A few weeks ago, Daniel Vorhaus from the Genomics Law Report asked me to provide a commentary on what I think about the future of personalized medicine regarding ethical, legal and social aspects. Now my commentary was published and here is an excerpt:
Educating medical professionals and preparing the public to be able to provide informed consent for these activities is crucial to this next phase; as is the accessibility of the enormous and growing amount of genomic data. A new generation of web services, the so-called web 2.0, seems to be playing an important role in this movement. Through such tools, people can interact with their doctors and each other easily and they can share the results of genomic tests, resulting in a self-maintained database of human genomic information. Examples include the research project of 23andMe.com or the amyotrophic lateral sclerosis research of Patientslikeme.com.
Check out the whole list of contributors.